Regencell Bioscience Holdings Stock Today
| RGC Stock | USD 5.10 0.60 10.53% |
Performance0 of 100
| Odds Of DistressLess than 6
|
Regencell Bioscience is trading at 5.10 as of the 25th of April 2024, a -10.53 percent decrease since the beginning of the trading day. The stock's open price was 5.7. Regencell Bioscience has only a 6 % chance of going through financial distress over the next few years, but has generated negative returns over the last 90 days. Equity ratings for Regencell Bioscience Holdings are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of March 2024 and ending today, the 25th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 16th of July 2021 | Category Healthcare | Classification Health Care |
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine bioscience company. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong. Regencell Bioscience operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. The company has 13.01 M outstanding shares of which 3.94 K shares are at this time shorted by investors with about 0.6 days to cover. More on Regencell Bioscience Holdings
Moving against Regencell Stock
| 0.89 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
| 0.8 | XFOR | X4 Pharmaceuticals Earnings Call This Week | PairCorr |
| 0.78 | VKTX | Viking Therapeutics Potential Growth | PairCorr |
| 0.76 | NRSNW | NeuroSense Therapeutics | PairCorr |
| 0.65 | LLY | Eli Lilly Earnings Call This Week | PairCorr |
| 0.57 | CGC | Canopy Growth Corp Trending | PairCorr |
| 0.55 | BMY | Bristol Myers Squibb Earnings Call Today | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Regencell Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Regencell Bioscience's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Regencell Bioscience or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairperson and CEO | Amy Miles | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Compulsion (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Names | [Heliostar Metals Ltd, PV - Inconess Investment Corp, Regal Entertainment Group] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Compulsion, Health Care, Biotechnology, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the measurements of operating efficiency obtained from Regencell Bioscience's historical financial statements, Regencell Bioscience Holdings may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. Financial strength of Regencell Bioscience is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Regencell Bioscience's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Regencell Bioscience's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Regencell Bioscience's financial leverage. It provides some insight into what part of Regencell Bioscience's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Regencell Bioscience Holdings (RGC) is traded on NASDAQ Exchange in USA. It is located in Chinachem Leighton Plaza, Causeway Bay, Hong Kong and employs 12 people. Regencell Bioscience is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a total capitalization of 74.17 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Regencell Bioscience's market, we take the total number of its shares issued and multiply it by Regencell Bioscience's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Regencell Bioscience runs under Biotechnology sector within Health Care industry. The entity has 13.01 M outstanding shares of which 3.94 K shares are at this time shorted by investors with about 0.6 days to cover.
Regencell Bioscience Holdings has about 59.41 K in cash with (4.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check Regencell Bioscience Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Regencell Bioscience is $74.17 Million. Regencell Bioscience holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 88.76 pct. of Regencell Bioscience outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Regencell Ownership Details
Regencell Stock Price Odds Analysis
What are Regencell Bioscience's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Regencell Bioscience jumping above the current price in 90 days from now is about 69.15%. The Regencell Bioscience Holdings probability density function shows the probability of Regencell Bioscience stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon the stock has a beta coefficient of 1.0223 indicating Regencell Bioscience Holdings market returns are highly-sensitive to returns on the market. As the market goes up or down, Regencell Bioscience is expected to follow. Additionally, regencell Bioscience Holdings has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Regencell Bioscience to move above the current price in 90 days from now is about 69.15 (This Regencell Bioscience Holdings probability density function shows the probability of Regencell Stock to fall within a particular range of prices over 90 days) .
Regencell Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Regencell Bioscience that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Regencell Bioscience's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Regencell Bioscience's value.| Instituion | Recorded On | Shares | |
| Ubs Group Ag | 2023-12-31 | 16.1 K | |
| Blackrock Inc | 2023-12-31 | 238 | |
| Qube Research & Technologies | 2023-12-31 | 13.0 | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 0.0 | |
| Tower Research Capital Llc | 2023-12-31 | 0.0 |
Regencell Bioscience Historical Income Statement
Regencell Bioscience Holdings Income Statement is one of the three primary financial statements used for reporting Regencell's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Regencell Bioscience revenue and expense. Regencell Bioscience Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Regencell Bioscience's Selling And Marketing Expenses is projected to increase significantly based on the last few years of reporting. The current year's Reconciled Depreciation is expected to grow to about 929.4 K, whereas Depreciation And Amortization is forecasted to decline to about 658.1 K. View More FundamentalsRegencell Stock Against Markets
Picking the right benchmark for Regencell Bioscience stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Regencell Bioscience stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Regencell Bioscience is critical whether you are bullish or bearish towards Regencell Bioscience Holdings at a given time. Please also check how Regencell Bioscience's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Regencell Bioscience without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Regencell Bioscience Corporate Directors
Regencell Bioscience corporate directors refer to members of a Regencell Bioscience board of directors. The board of directors generally takes responsibility for the Regencell Bioscience's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Regencell Bioscience's board members must vote for the resolution. The Regencell Bioscience board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| YiChung Chao | Special Director | Profile | |
| Jeffrey Pontius | Independent Director | Profile | |
| Jack Tyrrell | Independent Director | Profile | |
| Thomas Bell | Lead Independent Director | Profile |
How to buy Regencell Stock?
Before investing in Regencell Bioscience, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Regencell Bioscience. To buy Regencell Bioscience stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Regencell Bioscience. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Regencell Bioscience stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Regencell Bioscience Holdings stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Regencell Bioscience Holdings stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Regencell Bioscience Holdings, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Regencell Stock please use our How to Invest in Regencell Bioscience guide.
Already Invested in Regencell Bioscience Holdings?
The danger of trading Regencell Bioscience Holdings is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Regencell Bioscience is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Regencell Bioscience. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Regencell Bioscience is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Regencell Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Regencell Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Regencell Bioscience Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Regencell Bioscience Holdings Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regencell Bioscience Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Regencell Bioscience information on this page should be used as a complementary analysis to other Regencell Bioscience's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for Regencell Stock analysis
When running Regencell Bioscience's price analysis, check to measure Regencell Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regencell Bioscience is operating at the current time. Most of Regencell Bioscience's value examination focuses on studying past and present price action to predict the probability of Regencell Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regencell Bioscience's price. Additionally, you may evaluate how the addition of Regencell Bioscience to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets |
Is Regencell Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regencell Bioscience. If investors know Regencell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regencell Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.45) | Return On Assets (0.26) | Return On Equity (0.42) |
The market value of Regencell Bioscience is measured differently than its book value, which is the value of Regencell that is recorded on the company's balance sheet. Investors also form their own opinion of Regencell Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Regencell Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regencell Bioscience's market value can be influenced by many factors that don't directly affect Regencell Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regencell Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Regencell Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regencell Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.